Mechanisms of statin-induced myopathy - A role for the ubiquitin-proteasome pathway?

被引：25

作者：

Chapman, MJ ^{[1
]}

Carrie, A

机构：

[1] INSERM, Dyslipidemia & Atherosclerosis Res Unit, Hop Pitie, U551, 83 Blvd Hop, F-75651 Paris, France

[2] Univ Paris 06, F-75252 Paris, France

[3] Hop Pitie, Dept Biochem Med, APHP, Mol Endocrinol Unit, F-75651 Paris, France

来源：

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2005年 / 25卷 / 12期

关键词：

D O I：

10.1161/01.ATV.0000194548.11901.a4

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：2441 / 2444

页数：4

共 19 条

[1]

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].

Baigent, C ;

Keech, A ;

Kearney, PM ;

Blackwell, L ;

Buck, G ;

Pollicino, C ;

Kirby, A ;

Sourjina, T ;

Peto, R ;

Collins, R ;

Simes, J .

LANCET, 2005, 366 (9493) :1267-1278

[2]

Risk for myopathy with statin therapy in high-risk patients [J].

Ballantyne, CM ;

Corsini, A ;

Davidson, MH ;

Holdaas, H ;

Jacobson, TA ;

Leitersdorf, E ;

März, W ;

Reckless, JPD ;

Stein, EA .

ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (05) :553-564

[3]

Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].

Cannon, CP ;

Braunwald, E ;

McCabe, CH ;

Rader, DJ ;

Rouleau, JL ;

Belder, R ;

Joyal, SV ;

Hill, KA ;

Pfeffer, MA ;

Skene, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504

[4]

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes - Phase Z of the A to Z trial [J].

de Lemos, JA ;

Blazing, MA ;

Wiviott, SD ;

Lewis, EF ;

Fox, KAA ;

White, HD ;

Rouleau, JL ;

Pedersen, TR ;

Gardner, LH ;

Mukherjee, R ;

Ramsey, KE ;

Palmisano, J ;

Bilheimer, DW ;

Pfeffer, MA ;

Califf, RM ;

Braunwald, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (11) :1307-1316

[5]

The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction [J].

Glickman, MH ;

Ciechanover, A .

PHYSIOLOGICAL REVIEWS, 2002, 82 (02) :373-428

[6]

Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass [J].

Jones, SW ;

Hill, RJ ;

Krasney, PA ;

O'Conner, B ;

Peirce, N ;

Greenhaff, PL .

FASEB JOURNAL, 2004, 18 (06) :1025-+

[7]

Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J].

LaRosa, JC ;

Grundy, SM ;

Waters, DD ;

Shear, C ;

Barter, P ;

Fruchart, J ;

Gotto, AM ;

Greten, H ;

Kastelein, JJP ;

Shepherd, J ;

Wenger, NK .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) :1425-1435

[8]

Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions [J].

Mason, RP ;

Walter, MF ;

Day, CA ;

Jacob, RF .

AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (5A) :11F-23F

[9]

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial [J].

Nissen, SE ;

Tuzcu, EM ;

Schoenhagen, P ;

Brown, BG ;

Ganz, P ;

Vogel, RA ;

Crowe, T ;

Howard, G ;

Cooper, CJ ;

Brodie, B ;

Grines, CL ;

DeMaria, AN .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (09) :1071-1080

[10]

High-dose statins and skeletal muscle metabolism in humans:: A randomized, controlled trial [J].

Päivä, H ;

Thelen, KM ;

Van Coster, R ;

Smet, J ;

De Paepe, B ;

Mattila, KM ;

Laakso, J ;

Lehtimäki, T ;

von Bergmann, K ;

Lütjohann, D ;

Laaksonen, R .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (01) :60-68

← 1 2 →